DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0006826 | Malignant Neoplasms | PIGU | 128869 | phosphatidylinositol glycan anchor biosynthesis class U | Q9H490 |
C0006142 | Malignant neoplasm of breast | PIGU | 128869 | phosphatidylinositol glycan anchor biosynthesis class U | Q9H490 |
C1837315 | COLORECTAL CANCER, SUSCEPTIBILITY TO, 1 | PIGU | 128869 | phosphatidylinositol glycan anchor biosynthesis class U | Q9H490 |
C3554460 | COLORECTAL CANCER, SUSCEPTIBILITY TO, 12 | PIGU | 128869 | phosphatidylinositol glycan anchor biosynthesis class U | Q9H490 |
C0678222 | Breast Carcinoma | PIGU | 128869 | phosphatidylinositol glycan anchor biosynthesis class U | Q9H490 |
C0036572 | Seizures | PIGU | 128869 | phosphatidylinositol glycan anchor biosynthesis class U | Q9H490 |
C0235946 | Cerebral atrophy | PIGU | 128869 | phosphatidylinositol glycan anchor biosynthesis class U | Q9H490 |
C0346629 | Malignant neoplasm of large intestine | PIGU | 128869 | phosphatidylinositol glycan anchor biosynthesis class U | Q9H490 |
C0009402 | Colorectal Carcinoma | PIGU | 128869 | phosphatidylinositol glycan anchor biosynthesis class U | Q9H490 |
C0007114 | Malignant neoplasm of skin | PIGU | 128869 | phosphatidylinositol glycan anchor biosynthesis class U | Q9H490 |
C2931822 | Nasopharyngeal carcinoma | PIGU | 128869 | phosphatidylinositol glycan anchor biosynthesis class U | Q9H490 |
C0699791 | Stomach Carcinoma | ADH5 | 128 | alcohol dehydrogenase 5 (class III), chi polypeptide | P11766 |
C0006826 | Malignant Neoplasms | ADH5 | 128 | alcohol dehydrogenase 5 (class III), chi polypeptide | P11766 |
C0242379 | Malignant neoplasm of lung | ADH5 | 128 | alcohol dehydrogenase 5 (class III), chi polypeptide | P11766 |
C0030312 | Pancytopenia | ADH5 | 128 | alcohol dehydrogenase 5 (class III), chi polypeptide | P11766 |
C0007107 | Malignant neoplasm of larynx | ADH5 | 128 | alcohol dehydrogenase 5 (class III), chi polypeptide | P11766 |
C0037231 | Sjogren-Larsson Syndrome | ADH5 | 128 | alcohol dehydrogenase 5 (class III), chi polypeptide | P11766 |
C0279626 | Squamous cell carcinoma of esophagus | ADH5 | 128 | alcohol dehydrogenase 5 (class III), chi polypeptide | P11766 |
C0024623 | Malignant neoplasm of stomach | ADH5 | 128 | alcohol dehydrogenase 5 (class III), chi polypeptide | P11766 |
C0595989 | Carcinoma of larynx | ADH5 | 128 | alcohol dehydrogenase 5 (class III), chi polypeptide | P11766 |
C0007124 | Noninfiltrating Intraductal Carcinoma | ADH5 | 128 | alcohol dehydrogenase 5 (class III), chi polypeptide | P11766 |
C0001339 | Acute pancreatitis | ADH5 | 128 | alcohol dehydrogenase 5 (class III), chi polypeptide | P11766 |
C0027651 | Neoplasms | ADH5 | 128 | alcohol dehydrogenase 5 (class III), chi polypeptide | P11766 |
C2239176 | Liver carcinoma | ADH5 | 128 | alcohol dehydrogenase 5 (class III), chi polypeptide | P11766 |
C0003850 | Arteriosclerosis | ADH5 | 128 | alcohol dehydrogenase 5 (class III), chi polypeptide | P11766 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024